Soutenir la recherche

Publications et ressources

Trier par :
Afficher :
121-130 sur 397

Sleeve Gastrectomy After Liver Transplantation: Feasibility and Outcomes

M Osseis, A Lazzati, C Salloum, CG Gavara, P Compagnon, Cyrille FERAY, C Lim, D Azoulay,

Obes Surg. 03/08/2017;. : . 10.1007/s11695-017-2843-y.

Heterotopic liver retransplantation for impossible former graft explantation.

D Azoulay, E Lahat, C Salloum, P Compagnon, Cyrille FERAY,

Hepatology. 01/08/2017;66(2) : 655-657 10.1002/hep.29077. 22/06/2017

Five cases of acute Zika virus infection in French women of reproductive age returning from Central and South America

P Penot, S Balavoine, A Leplatois, Ségolène BRICHLER, I Leparc-Goffart, C Alloui, O Flusin, J Guilleminot, M Amellou, JM Molina,

Rev Med Interne. 01/08/2017;38(8) : 547-550 10.1016/j.revmed.2016.12.011 16/01/2017

External validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry.

A Winter, Cyrille FERAY, E Audureau, R Ecochard, C Jacquelinet, F Roudot-Thoraval, C Duvoux, JP Daures, P Landais,

Liver Int. 01/08/2017;37(8) : 1229-1238 10.1111/liv.13378. 23/02/2017

NS5A inhibitors in the treatment of hepatitis C.

Jean-Michel PAWLOTSKY,

J Hepatol. 24/07/2017;59(2) : 375-382 10.1016/j.jhep.2013.03.030. 06/04/2013

Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers part 2: Neuroendocrine tumours, hepatocellular carcinoma, and gastro-intestinal stromal tumours

C Neuzillet, L de Mestier, Benoit ROUSSEAU, O Mir, M Hebbar, HM Kocher, P Ruszniewski, C Tournigand,

Pharmacol Ther. 16/07/2017;pii: S0163-7258(17) : 30166-3 10.1016/j.pharmthera.2017.07.006

An Oxygenated and Transportable Machine Perfusion System Fully Rescues Liver Grafts Exposed to Lethal Ischemic Damage in a Pig Model of DCD Liver Transplantation

P Compagnon, E Levesque, H Hentati, M Disabato, Julien CALDERARO, Cyrille FERAY, JL Cohen, I Ben Mosbah, D Azoulay,

Transplantation. 01/07/2017;101(7) : e205-e213 10.1097/TP.0000000000001764.

HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients.

JK Rockstroh, JJ Feld, Stephane CHEVALIEZ, K Cheng, H Wedemeyer, C Sarrazin, B Maasoumy, C Herman, J Hackett, DE Cohen, GJ Dawson, G Cloherty, Jean-Michel PAWLOTSKY,

J Virol Methods. 01/07/2017;245 : 14-18 10.1016/j.jviromet.2017.03.002. 27/03/2017

Afficher :
121-130 sur 397